JP2015531354A5 - - Google Patents

Download PDF

Info

Publication number
JP2015531354A5
JP2015531354A5 JP2015533438A JP2015533438A JP2015531354A5 JP 2015531354 A5 JP2015531354 A5 JP 2015531354A5 JP 2015533438 A JP2015533438 A JP 2015533438A JP 2015533438 A JP2015533438 A JP 2015533438A JP 2015531354 A5 JP2015531354 A5 JP 2015531354A5
Authority
JP
Japan
Prior art keywords
xrpd
peak
powder
ray diffraction
crystal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015533438A
Other languages
English (en)
Japanese (ja)
Other versions
JP6310923B2 (ja
JP2015531354A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2013/084383 external-priority patent/WO2014048355A1/en
Publication of JP2015531354A publication Critical patent/JP2015531354A/ja
Publication of JP2015531354A5 publication Critical patent/JP2015531354A5/ja
Application granted granted Critical
Publication of JP6310923B2 publication Critical patent/JP6310923B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015533438A 2012-09-27 2013-09-27 ジヒドロピリミジン誘導体の結晶形 Active JP6310923B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201210369019.4 2012-09-27
CN201210369019 2012-09-27
CN201310117076.8 2013-04-04
CN201310117076 2013-04-04
PCT/CN2013/084383 WO2014048355A1 (en) 2012-09-27 2013-09-27 Crystalline forms of dihydropyrimidine derivatives

Publications (3)

Publication Number Publication Date
JP2015531354A JP2015531354A (ja) 2015-11-02
JP2015531354A5 true JP2015531354A5 (enExample) 2018-02-08
JP6310923B2 JP6310923B2 (ja) 2018-04-11

Family

ID=50355923

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015533438A Active JP6310923B2 (ja) 2012-09-27 2013-09-27 ジヒドロピリミジン誘導体の結晶形

Country Status (20)

Country Link
US (1) US9403814B2 (enExample)
EP (1) EP2900664B1 (enExample)
JP (1) JP6310923B2 (enExample)
KR (1) KR20150060610A (enExample)
CN (3) CN103694234A (enExample)
AU (1) AU2013324779B2 (enExample)
BR (1) BR112015002979B8 (enExample)
CA (1) CA2881260C (enExample)
DK (1) DK2900664T3 (enExample)
ES (1) ES2660642T3 (enExample)
HU (1) HUE037285T2 (enExample)
MX (1) MX362829B (enExample)
MY (1) MY171497A (enExample)
PL (1) PL2900664T3 (enExample)
PT (1) PT2900664T (enExample)
RU (1) RU2646599C2 (enExample)
SG (1) SG11201500145TA (enExample)
TW (1) TWI561520B (enExample)
WO (1) WO2014048355A1 (enExample)
ZA (1) ZA201500290B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6113285B2 (ja) * 2012-09-10 2017-04-12 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft B型肝炎ウイルス感染症の治療及び予防用の6−アミノ酸ヘテロアリールジヒドロピリミジン
WO2017076286A1 (zh) * 2015-11-04 2017-05-11 南京明德新药研发股份有限公司 二氢吡啶并环化合物的晶型、制备方法和中间体
CN107400125B (zh) * 2016-05-19 2020-02-11 广东东阳光药业有限公司 二氢嘧啶衍生物的晶型、盐和复合物及其在药物中的应用
CN107722109B (zh) * 2016-08-11 2020-12-18 广东东阳光药业有限公司 作为丙型肝炎病毒抑制剂的晶型
US9856232B1 (en) * 2017-06-20 2018-01-02 King Saud University Dihydropyrimidinone derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR043880A1 (es) * 2003-04-22 2005-08-17 Solvay Pharm Gmbh Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas
WO2008154819A1 (fr) 2007-06-18 2008-12-24 Zhang, Zhongneng Thiazolyl-dihydropyrimidines à substitution carbéthoxy
USRE45004E1 (en) * 2007-06-18 2014-07-08 Sunshine Lake Pharma Co., Ltd. Bromo-phenyl substituted thiazolyl dihydropyrimidines
CN101328170B (zh) 2007-06-18 2011-09-14 张中能 一种氟苯基-取代噻唑二氢嘧啶
CN101328168B (zh) 2007-06-18 2011-09-07 张中能 一种乙氧碳酰基-取代噻唑二氢嘧啶
WO2010069147A1 (zh) * 2008-12-17 2010-06-24 张中能 二氢嘧啶类化合物、其组合物及其应用
CN101744823B (zh) * 2008-12-17 2013-06-19 广东东阳光药业有限公司 一种二氢嘧啶类化合物的固体分散体及其药用制剂

Similar Documents

Publication Publication Date Title
JP2021530565A5 (enExample)
JP2014501282A5 (enExample)
JP2015531354A5 (enExample)
JP2019504103A5 (enExample)
JP2012233154A5 (enExample)
JP2015520140A5 (enExample)
JP2019514863A5 (enExample)
ES2613716T3 (es) Formas cristalinas de un derivado de purina
JP2019505533A5 (enExample)
JP2020512316A5 (enExample)
JP2018115191A5 (enExample)
JP2007532560A5 (enExample)
JP2016510768A5 (enExample)
JP2020511461A5 (enExample)
JP2013516473A5 (enExample)
JP2013538849A5 (enExample)
JP2010132668A5 (enExample)
JP2015522037A5 (enExample)
JP2013503134A5 (enExample)
JP2016537326A5 (enExample)
JP2021514967A5 (enExample)
JP2012176989A5 (enExample)
JP2018520147A5 (enExample)
JP2013544854A5 (enExample)
JP2015506987A5 (enExample)